<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.huliq.com" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>anti-anginal medication</title>
 <link>http://www.huliq.com/tags/anti-anginal-medication</link>
 <description>The taxonomy view with a depth of 0.</description>
 <language>en</language>
<item>
 <title>Angina drug potentially useful against heart rhythm disorders</title>
 <link>http://www.huliq.com/55521/angina-drug-potentially-useful-against-heart-rhythm-disorders</link>
 <description>A recently approved angina drug may also represent a powerful new treatment for a rare hereditary syndrome that places teens at risk for &lt;strong&gt;sudden cardiac death&lt;/strong&gt;, according to research presented to today at the 57th Annual Scientific Sessions of the American College of Cardiology (ACC) in Chicago.</description>
 <comments>http://www.huliq.com/55521/angina-drug-potentially-useful-against-heart-rhythm-disorders#comments</comments>
 <category domain="http://www.huliq.com/health">Health</category>
 <category domain="http://www.huliq.com/tags/anti-anginal-medication">anti-anginal medication</category>
 <category domain="http://www.huliq.com/tags/cardiac-problems">cardiac problems</category>
 <category domain="http://www.huliq.com/tags/heart-rhythm-disorders">heart rhythm disorders</category>
 <category domain="http://www.huliq.com/tags/sudden-cardiac-death">sudden cardiac death</category>
 <pubDate>Tue, 01 Apr 2008 00:54:42 -0500</pubDate>
 <dc:creator>harminka</dc:creator>
 <guid isPermaLink="false">55521 at http://www.huliq.com</guid>
</item>
<item>
 <title>New efficacy data for unique anti-anginal therapy</title>
 <link>http://www.huliq.com/16661/new-efficacy-data-for-unique-anti-anginal-therapy</link>
 <description>&lt;strong&gt;Chest pain&lt;/strong&gt; due to a shortage of blood in the heart, known as angina, is a condition that affects millions of Americans. The most recently approved new pharmaceutical approach to treat chronic angina is a novel drug called ranolazine, which was approved in 2006 for use as second line therapy in patients who continue to experience angina despite treatment with another class of anti-anginal medication. </description>
 <comments>http://www.huliq.com/16661/new-efficacy-data-for-unique-anti-anginal-therapy#comments</comments>
 <category domain="http://www.huliq.com/health">Health</category>
 <category domain="http://www.huliq.com/tags/angina">angina</category>
 <category domain="http://www.huliq.com/tags/anti-anginal-medication">anti-anginal medication</category>
 <category domain="http://www.huliq.com/tags/chest-pain">chest pain</category>
 <category domain="http://www.huliq.com/tags/ischemia">Ischemia</category>
 <category domain="http://www.huliq.com/tags/ranolazine">ranolazine</category>
 <pubDate>Tue, 27 Mar 2007 13:59:13 -0500</pubDate>
 <dc:creator>harminka</dc:creator>
 <guid isPermaLink="false">16661 at http://www.huliq.com</guid>
</item>
</channel>
</rss>
